AUSTCANCER APPOINTS SINGAPORE DISTRIBUTOR FOR REVISYS.Australian Cancer Technology Limited ("AustCancer") (ASX ASX See: Australian Stock Exchange : ACU ACU See: Asian currency units ) has announced that its US subsidiary, ACT (USA) Inc, has appointed Hengzi Technology Investment Pte Ltd as exclusive distributor of the revisys range of nutritional supplements Nutritional Supplements Definition Nutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. in Singapore. This is the first distribution deal for the products in a market outside the United States. Hengzi Technology is a specialist supplier to health professionals in the Asia Pacific region where it markets and distributes a range of medical devices and pharmaceutical products on behalf of a number of prominent international healthcare companies. The company is in partnership with VRI VRI Vacation Register International VRI Video Relay Interpreting VRI Vehicle Research Institute (Western Washington University, Bellingham, Washington) VRI Venture Research Institute (Lake Forest, California) BioMedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , an Australian biotechnology company, in establishing its Gastointestinal Health Products in S.E. Asia & South Asia. Hengzi Technology director, Lim Linbert, sees the revisys range satisfying a growing need in the Singapore market for premium nutritional supplements. "Most western medicine patients in Singapore would also seek complementary medicines for their conditions. There is an increasing call for complementary products that are backed by sound medical science," Lim said. Revisys is an integrated, multi-level nutrient system that provides support for four levels of health and nutritional needs, from general well-being to condition-specific supplementation. It is particularly designed for patients facing unique nutritional requirements nutritional requirements, n the food and liquids necessary for normal physiologic function. due to extenuating ex·ten·u·ate tr.v. ex·ten·u·at·ed, ex·ten·u·at·ing, ex·ten·u·ates 1. To lessen or attempt to lessen the magnitude or seriousness of, especially by providing partial excuses. See Synonyms at palliate. 2. health issues. Developed by leading medical scientists and launched in the United States in February this year, revisys aims to become the leading choice of medical professionals for scientifically credible, high quality nutritional supplements. AustCancer managing director Paul Hopper said, "We've made good early progress in penetrating the United States market with revisys and we are now ready to start developing a position in other markets. Singapore intrinsically appeals as a strong potential market for us and if it meets our expectations, expansion into other Asian countries would be a logical next step." The revisys products will be launched into the Singapore market in November this year. The products' developers, the prominent US medical scientists Professor David Felten and Professor Barry Boyd, will introduce revisys in a series of presentations to Singapore oncologists and other health professionals. The critical success factor is to convince Medical practitioners in Singapore that revisys products and value proposition are superior. Product for the Singapore market will be manufactured by ACT (USA) in Australia, where plans are also underway to launch revisys by December 2004 ACT (USA) has estimated that total (domestic and export) sales of revisys will be of the order of US$8-10 million pa by 2006. For more information, call 585-419-9710. Australian Cancer Technology Australian Cancer Technology is a broadly based international oncology company developing a portfolio of high quality oncology-related projects that are at various stages of commercialization. Cash generating businesses will provide the funds to exploit the potential of its leading products and to introduce promising pre-clinical and Phase I projects into the development pipeline. Its leading edge Pentrys anti-cancer vaccine successfully completed Phase I and Phase I/IIa trials at St. Vincent's Hospital Hospital:
in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on (AUCJY). For more information, visit http://www.austcancer.com.au and http://www.revisyshealth.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion